Conversion to GA4 · women having spinal anaesthesia for caesarean section
It is very uncertain whether hyperbaric bupivacaine changes conversion to GA4 compared with isobaric bupivacaine (very low certainty).
1 finding from 1 review
Supplemental analgesia5 · women having spinal anaesthesia for caesarean section
It is very uncertain whether hyperbaric bupivacaine changes supplemental analgesia5 compared with isobaric bupivacaine (very low certainty).
1 finding from 1 review
Requirement for ephedrine6 · women having spinal anaesthesia for caesarean section
It is very uncertain whether hyperbaric bupivacaine changes requirement for ephedrine6 compared with isobaric bupivacaine (very low certainty).
1 finding from 1 review
Nausea and vomiting7 · women having spinal anaesthesia for caesarean section
Hyperbaric bupivacaine showed no clear difference in nausea and vomiting7 compared with isobaric bupivacaine (low certainty).
1 finding from 1 review
Headache8 Participant‐reported · women having spinal anaesthesia for caesarean section
Hyperbaric bupivacaine showed no clear difference in headache8 Participant‐reported compared with isobaric bupivacaine (low certainty).
1 finding from 1 review
Time to dermatomal block T4 block (mins) · women having spinal anaesthesia for caesarean section
1 finding from 1 review
Amount of ephedrine used(mg/person) · women having spinal anaesthesia for caesarean section
1 finding from 1 review
Long‐term mortality · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Mortality before hospital discharge · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
It is very uncertain whether inhaled nitric oxide changes mortality prior to discharge1 compared with placebo or conventional therapy (very low certainty).
1 finding from 1 review
Difference in MPAP change score (SE) ‐ Conventional Management4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Difference in MPAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
no estimate extracted
1 study · 2 participants
Very low
Difference in MAP change score (SE) ‐ Conventional Mangement4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Difference in MAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
no estimate extracted
1 study · 2 participants
Very low
Major complications · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes major complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Mortality within the longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes all‐cause mortality (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Length of hospital stay · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes length of hospital stay (days) compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Surgery‐related complications (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes surgery‐related complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Non‐surgery‐related complications (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes non‐surgery‐related complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Renal failure · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes renal failure (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Quality of surgical recovery assessed in any way (e.g. as a surgical recovery score) (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
1 finding from 1 review